Cargando…
Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE(−/−) mice
Increasing evidence suggests thrombospondin-1 (TSP-1), a potent proatherogenic matricellular protein, as a putative link between hyperglycemia and atherosclerotic complications in diabetes. We previously reported that the micronutrient chromium picolinate (CrP), with long-standing cardiovascular ben...
Autores principales: | Ganguly, Rituparna, Sahu, Soumyadip, Ohanyan, Vahagn, Haney, Rebecca, Chavez, Ronaldo J., Shah, Shivani, Yalamanchili, Siri, Raman, Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366888/ https://www.ncbi.nlm.nih.gov/pubmed/28345659 http://dx.doi.org/10.1038/srep45279 |
Ejemplares similares
-
Hyperglycemia-Induced Metabolic Reprogramming Mediates a Proatherogenic Phenotype in Healthy Human Monocytes
por: Castro-Grattoni, Anabel Lourdes, et al.
Publicado: (2021) -
Chromium Picolinate Protects against Testicular Damage in STZ-Induced Diabetic Rats via Anti-Inflammation, Anti-Oxidation, Inhibiting Apoptosis, and Regulating the TGF-β1/Smad Pathway
por: Zheng, Hongxing, et al.
Publicado: (2023) -
Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat
por: Mozaffari, Mahmood S, et al.
Publicado: (2009) -
The Effect of Chromium Nanoparticles and Chromium Picolinate in the Diet of Chickens on Levels of Selected Hormones and Tissue Antioxidant Status
por: Stępniowska, Anna, et al.
Publicado: (2019) -
Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Qi, Shan Shan, et al.
Publicado: (2020)